Glucose abnormalities in Asian patients with chronic hepatitis C
Qingyan Bo,1 Roberto Orsenigo,2 Junyi Wang,1 Louis Griffel,3 Clifford Brass3 1Beijing Novartis Pharma Co. Ltd., Shanghai, People’s Republic of China; 2Novartis Pharma AG, Basel, Switzerland; 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA Abstract: Many studies have demonstr...
Main Authors: | Bo Q, Orsenigo R, Wang J, Griffel L, Brass C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-11-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | https://www.dovepress.com/glucose-abnormalities-in-asian-patients-with-chronic-hepatitis-c-peer-reviewed-article-DDDT |
Similar Items
-
Glucose abnormalities in hepatitis C virus infection
by: Jee-Fu Huang, et al.
Published: (2013-02-01) -
The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agents
by: Jee-Fu Huang, et al.
Published: (2017-11-01) -
Growth Abnormalities in Children with Chronic Hepatitis B or C
by: P. Gerner, et al.
Published: (2012-01-01) -
Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C.
by: Chao-Min Huang, et al.
Published: (2017-01-01) -
Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C
by: Shih-Jer Hsu, et al.
Published: (2019-08-01)